Avalo Therapeutics Statistics
Total Valuation
AVTX has a market cap or net worth of $326.41 million. The enterprise value is $215.35 million.
Important Dates
The last earnings date was Thursday, November 6, 2025, before market open.
| Earnings Date | Nov 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
AVTX has 18.13 million shares outstanding. The number of shares has increased by 450.90% in one year.
| Current Share Class | 18.13M |
| Shares Outstanding | 18.13M |
| Shares Change (YoY) | +450.90% |
| Shares Change (QoQ) | +29.28% |
| Owned by Insiders (%) | 3.48% |
| Owned by Institutions (%) | 50.98% |
| Float | 10.42M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1,700.06 |
| Forward PS | n/a |
| PB Ratio | 3.51 |
| P/TBV Ratio | 4.03 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1,121.61 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 14.28, with a Debt / Equity ratio of 0.01.
| Current Ratio | 14.28 |
| Quick Ratio | 14.00 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -174.79% and return on invested capital (ROIC) is -71.36%.
| Return on Equity (ROE) | -174.79% |
| Return on Assets (ROA) | -37.18% |
| Return on Invested Capital (ROIC) | -71.36% |
| Return on Capital Employed (ROCE) | -56.77% |
| Revenue Per Employee | $8,348 |
| Profits Per Employee | -$4.33M |
| Employee Count | 23 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, AVTX has paid $149,000 in taxes.
| Income Tax | 149,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +77.69% in the last 52 weeks. The beta is 0.86, so AVTX's price volatility has been lower than the market average.
| Beta (5Y) | 0.86 |
| 52-Week Price Change | +77.69% |
| 50-Day Moving Average | 14.93 |
| 200-Day Moving Average | 8.63 |
| Relative Strength Index (RSI) | 62.55 |
| Average Volume (20 Days) | 355,843 |
Short Selling Information
The latest short interest is 1.35 million, so 7.42% of the outstanding shares have been sold short.
| Short Interest | 1.35M |
| Short Previous Month | 1.30M |
| Short % of Shares Out | 7.42% |
| Short % of Float | 12.91% |
| Short Ratio (days to cover) | 3.55 |
Income Statement
In the last 12 months, AVTX had revenue of $192,000 and -$99.70 million in losses. Loss per share was -$8.74.
| Revenue | 192,000 |
| Gross Profit | -31.91M |
| Operating Income | -66.49M |
| Pretax Income | -99.73M |
| Net Income | -99.70M |
| EBITDA | -66.10M |
| EBIT | -66.49M |
| Loss Per Share | -$8.74 |
Full Income StatementBalance Sheet
The company has $111.62 million in cash and $555,000 in debt, giving a net cash position of $111.06 million or $6.12 per share.
| Cash & Cash Equivalents | 111.62M |
| Total Debt | 555,000 |
| Net Cash | 111.06M |
| Net Cash Per Share | $6.12 |
| Equity (Book Value) | 91.55M |
| Book Value Per Share | 5.14 |
| Working Capital | 105.87M |
Full Balance SheetCash Flow
| Operating Cash Flow | -52.26M |
| Capital Expenditures | n/a |
| Free Cash Flow | -52.26M |
| FCF Per Share | -$2.88 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -34,632.29% |
| Pretax Margin | -51,942.19% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
AVTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -450.90% |
| Shareholder Yield | -450.90% |
| Earnings Yield | -30.54% |
| FCF Yield | -16.01% |
Analyst Forecast
The average price target for AVTX is $30.14, which is 67.44% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $30.14 |
| Price Target Difference | 67.44% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (5Y) | 85.64% |
| EPS Growth Forecast (5Y) | -30.26% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on December 29, 2023. It was a reverse split with a ratio of 1:240.
| Last Split Date | Dec 29, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:240 |
Scores
AVTX has an Altman Z-Score of -4.05 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -4.05 |
| Piotroski F-Score | 2 |
